Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Jasper Therapeutics is a biotech company focused on developing therapies for mast cell-driven diseases such as chronic urticarias, asthma, and other inflammatory conditions. Its lead candidate, briquilimab, is a monoclonal antibody targeting the c-Kit receptor to deplete mast cells and support stem cell transplantation. The company advances clinical programs, collaborates with industry and academia, and seeks regulatory approval to bring innovative immune modulation treatments to patients worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.